EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS187-22593 
Organism
Homo sapiens 
Tissue/cell
Th1 
Coordinate
chr7:38406430-38408360 
TF binding sites/motifs
Number: 19             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
ALX3MA0634.1chr7:38407225-38407235TTTAATTAGA-6.02
CTCFMA0139.1chr7:38407914-38407933CATCGCCCTCTTGTGGCAG-6.41
EWSR1-FLI1MA0149.1chr7:38406541-38406559GGAAGGAAGGAAGGAAAG+10.53
EWSR1-FLI1MA0149.1chr7:38406558-38406576GAAAGGAAGGAGGGTGGG+6.09
EWSR1-FLI1MA0149.1chr7:38406593-38406611GGAAGGGAGGGAGGGAGA+6.25
EWSR1-FLI1MA0149.1chr7:38406632-38406650GGAAGTAAGAAAGGAGAG+6.26
EWSR1-FLI1MA0149.1chr7:38406533-38406551AAAAGCAAGGAAGGAAGG+6.64
EWSR1-FLI1MA0149.1chr7:38406585-38406603GGAAAGGAGGAAGGGAGG+6.88
EWSR1-FLI1MA0149.1chr7:38406554-38406572GAAAGAAAGGAAGGAGGG+7.43
EWSR1-FLI1MA0149.1chr7:38406581-38406599GGAAGGAAAGGAGGAAGG+8.08
EWSR1-FLI1MA0149.1chr7:38406545-38406563GGAAGGAAGGAAAGAAAG+8.46
EWSR1-FLI1MA0149.1chr7:38406537-38406555GCAAGGAAGGAAGGAAGG+9.25
SREBF1MA0595.1chr7:38406571-38406581GTGGGGTGAT-6.02
ZNF263MA0528.1chr7:38406542-38406563GAAGGAAGGAAGGAAAGAAAG+6.03
ZNF263MA0528.1chr7:38406591-38406612GAGGAAGGGAGGGAGGGAGAG+6.11
ZNF263MA0528.1chr7:38406563-38406584GAAGGAGGGTGGGGTGATGGA+6.13
ZNF263MA0528.1chr7:38406578-38406599GATGGAAGGAAAGGAGGAAGG+6.25
ZNF263MA0528.1chr7:38406590-38406611GGAGGAAGGGAGGGAGGGAGA+8.01
ZNF263MA0528.1chr7:38406587-38406608AAAGGAGGAAGGGAGGGAGGG+8.12
Number of super-enhancer constituents: 9             
IDCoordinateTissue/cell
SE_18878chr7:38405911-38410772CD4p_CD25-_Il17-_PMAstim_Th
SE_19970chr7:38406617-38408651CD56
SE_22542chr7:38405977-38412248CD8_primiary
SE_25751chr7:38406129-38408686DND41
SE_31238chr7:38406319-38408561Fetal_Thymus
SE_54260chr7:38406512-38408904Spleen
SE_55291chr7:38406665-38407694Thymus
SE_55291chr7:38407708-38408347Thymus
SE_61727chr7:38349626-38410131Toledo
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr73840667738407774
chr73840773538408281
Number: 1             
IDChromosomeStartEnd
GH07I038366chr73840626438410426
Enhancer Sequence
GCAGCTATAT CAATGTTGGC ATGAACAAAT AGAGAAAAAC TATTTCAAAT GATTTTGTGG 60
AAAAAGTATT GTGATTATGT ACACAAAAAG GAGAGAAAGA GAGAAAAGCA AGGAAGGAAG 120
GAAGGAAAGA AAGGAAGGAG GGTGGGGTGA TGGAAGGAAA GGAGGAAGGG AGGGAGGGAG 180
AGAAAATGAT AAAAGCAAGC ATGGAAGTAA GAAAGGAGAG CGAGAATAAA AGGGAGGGCA 240
GAGAGAGAGA ATGTTCAACT GCATATATTG GCCTAGTGTT TTAGTGGTCA TTATAGTATT 300
GCTTATATTG TTATAGACAT AAGGAATAAG CACCACTCTC AGCTGCGATC TCTGGACCAT 360
TATTGGATGT ATGATTCAGT ATGAATACCC TTCCCATTTT TGTCCAAAAT GTCTTGCTTC 420
ACAGCTGGAC CCTAGCTGTA CCTGTCTGTC CTAGGAAGCA GAGTGAGTGG GCCTTCCCCA 480
TGTTCTAGGA GAGCTGAGAG AAACTTGCTC TCAGCCAGGC TGCTTAGCTG AGGCTTGGAG 540
GTGGCAGCTT GGTCTTCAGG AAAGTCCTGG GGGAGGGTGG GGAACAGGGT GCAGCTGCTG 600
CCAGGGGAGT GTGATATTGC AGGGGAGATC AGGAGTTAAG CTGTGTTTCT CTTTGTACAG 660
AATACAGTAA ATTCAGGGCA GGAAATGAGA GTTGGCTGGT CTATCTTGTG TACCAGAAGC 720
AACCACAGGC AGATTTTCAG TGTCTGAATC ACTGTGCCTG TCCCAGGTGG CACAGTAATA 780
GAACCCAGAA TCATTTTTAA TTAGATTTTG CAGTCTCAAA TTCCAATTGC TCCTTGTGCT 840
TCCAGTGTCA TACTTTCCTG GAGTGATTCC TGATTCCAGC ACAACCCTGG AGTAGTAGGG 900
TTCATAGTAC AGAAGACACT GTGGGGCCTT CCCCTCCTGG TGCAGGTACC AGTGGATGTA 960
TAAGGTACTT GCTCCAGGAA GATCACAGGT GATTTCAGCA GATGACCCAG TCAGCCTGGT 1020
GACTGACTTC GTTCTCCCTT CCAAGTTGGA AGATATCTGA CTGGCTGCAA TGGGAACAAC 1080
ACAAAATATA ATGAGGCATT TCTTAGTATG TCGCTCCTTG CAAAAGAAGA AAATAACAAA 1140
ACAAAACAAA ACCCGTGATC CTCTCTGTAG GCAGCGCACT CACCAGGAGA CAGGAAAGCT 1200
AGAAGCACCG CTAGGGCCCA CCGCATGCCT TCCTCTCTGG GGCCTTGGAA GGAAAGGGAC 1260
CAGATGAAGA GGAGCAGAAG ATCCTCTTAA AACTCAGGCC CCACTCAACA AGGAAGTGAT 1320
CCCTAGCACA GAAGACAGTA AGAGGAGCTG GTCTTCCTGA GTCACAGGCA GGGAGAAGTG 1380
ACTGAGGATG TGTCTTAGGG GACTCCCAAG CCTTCCTCCC AGAAGCGGTG GTTCCTGGGA 1440
GGACCTGCAG AGGAGCTCCT GCCTCTCTGC TCAGGCCCGT TCTCCATCGC CCTCTTGTGG 1500
CAGCTGAGAG CAGGCCCTCT TCAGGAGAGA GCCAGGGGCA TGGATTGCTC AGGCCCACAG 1560
CAGAGGGAGT GCAGATGTGG GGGAAGCTGA CCCTGGCGCT AGCTGGTCAT GGCCCTTGGG 1620
AGAGGGCAGT CCCACAGCAG GCTCACATCC TGCACTTCAG AGTTTCAGCA GCCAACGCAG 1680
CTGCCAGAAC CTGGTCCTGC CAGGAAGCTT CTGATTAGGG CCCTGAACCA CCTTCCTTTT 1740
CACATTTGCA AGTCCACATT TGCAAGTCCA CCCAGGGCCA TTCTGAGAAG GCTTGAGCCT 1800
GCTTTATTAA CAGGACTGAG GGTCAGGCAT GTTGGTTTGC CTTGGACTCT ACTCAAATAA 1860
AAACAACGGC AGTGGCTCTC ACTAACCATC GGTAGGACAT TTTAAGCACC AAAAGAATAA 1920
CACCTACACA 1930